Gliptins and diabetes treatment - today and in the future

Abstract

A new class of oral hypoglycaemic agent today and in the future are described.

Keywords

• gliptins
• DPP-4 inhibitors
• oral antidiabetic agent combination
• monotherapy
• combination with insulin